Compare NEO & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEO | LTC |
|---|---|---|
| Founded | 2001 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2008 | 1994 |
| Metric | NEO | LTC |
|---|---|---|
| Price | $16.54 | $43.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 8 |
| Target Price | $21.85 | ★ $45.86 |
| AVG Volume (30 Days) | ★ 2.3M | 589.9K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 5.26% |
| EPS Growth | N/A | ★ 23.53 |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | ★ $262,854,000.00 |
| Revenue This Year | $10.71 | $66.77 |
| Revenue Next Year | $9.96 | $47.98 |
| P/E Ratio | ★ N/A | $41.28 |
| Revenue Growth | N/A | ★ 25.26 |
| 52 Week Low | $7.07 | $33.64 |
| 52 Week High | $20.15 | $44.30 |
| Indicator | NEO | LTC |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 62.61 |
| Support Level | $15.57 | $37.66 |
| Resistance Level | $16.92 | N/A |
| Average True Range (ATR) | 0.98 | 0.74 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 23.00 | 81.51 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.